A Champion Departs: Peter Marks’ Resignation and Biotech’s Crossroads
When Dr. Peter Marks walked out of the FDA’s headquarters
From Collapse to Comeback: Inside Biotech’s ‘Death-to-Rebirth’ Cycle
Layoffs Hit Biotech Hubs Hard In labs from Boston’s Kendall
Syngene’s Baltimore Bet: Indian Biotech’s American Ambitions and Global Supply Shake-Up
A few years ago, Emergent BioSolutions’ Bayview plant in Baltimore
Roche’s Bold Foray into Obesity Treatment: A $5.3 Billion Bet on Petrelintide
In a strategic move poised to reshape the landscape of
Breaking the Bias: How Precision Medicine Can Overcome Ancestral Disparities
In the rapidly advancing field of precision medicine, where treatments
The Billionaire Longevity Experiment: A Cruise Ship Promises to Extend Life—For a Price
For the wealthy and the wellness-obsessed, the pursuit of longevity
Tropic Unveils Gene-Edited Non-Browning Bananas to Reduce Food Waste
A New Era for Bananas: The Innovation That Could Change
AbbVie Enters Obesity Drug Market with $2.2B Gubra Licensing Deal
AbbVie, a leading biopharmaceutical company, has taken a significant step
How AI is Revolutionizing Antibiotic Discovery to Combat Drug-Resistant Bacteria
Antibiotic resistance poses a significant global health threat, rendering many
Metsera’s Weight-Loss Drug MET-097i Shows Strong Clinical Results
Obesity remains a critical public health challenge in the United
Michigan-Based Biotech Startup CircNova Secures $3.3M Seed Funding to Advance AI-Driven Circular RNA Therapies
CircNova, a Michigan-based biotechnology startup, has successfully raised $3.3 million
Illumina’s Market Struggles Deepen as U.S.-China Tensions Escalate
Illumina, a prominent biotech firm specializing in gene-sequencing technology, is
Breaking Barriers: BioArctic’s Blood-Brain Transport Technology and Its Impact on Neurological Drug Delivery
BioArctic, a Swedish biotechnology company renowned for its innovative approach
Merck KGaA in Talks to Acquire U.S. Biotech Firm SpringWorks, Valued at $4 Billion
Merck KGaA, Darmstadt, Germany, is reportedly in advanced negotiations to
Light-Based Microcapillary Monitoring Expands Precision in Biotechnology
Microcapillary technology, particularly light-based microcapillary monitoring, represents a significant advancement
Draupnir Bio Raises €12 Million to Advance Oral Protein Degraders Targeting Extracellular Proteins
Draupnir Bio, a cutting-edge biotechnology company, has successfully raised €12
Novo Holdings Leads $100 Million Series C Financing for Asceneuron
Novo Holdings has led a $100 million Series C financing
German Biotech CatalYm Raises $150 Million for Phase 2b Cancer Studies
CatalYm, a German biotech company specializing in cancer immunotherapy, has
Myricx Bio’s NMTi-ADCs Achieve Tumor Regression in Preclinical Trials
The field of cancer treatment is on the cusp of
Pharma Giant Eli Lilly to Buy Biotech Firm Morphic for $3.2 Billion
Eli Lilly and Company, a global leader in pharmaceutical development,
Brisbane Biotech Gelomics Raises $2.2 Million in Pre-Seed Funding
In a significant stride towards ethical biomedical advancements, Brisbane-based biotech
Alumis IPO Priced at $16, Targets $210M Funding
Alumis, a clinical-stage immunology biotech company, has priced its downsized
Unlocking New Frontiers: How Generative AI is Transforming Protein Design and Drug Discovery
Abstract This report explores the transformative impact of generative artificial
Manulife and World Economic Forum Launch Longevity Innovation Challenge
Manulife and World Economic Forum Launch Longevity Innovation Challenge In
MOST POPULAR
